This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookies Policy.

Banner Tittle 1 Banner Tittle 2 Banner Tittle 3

Scientific Program

Based on the abstracts received and accepted for oral presentation, general sessions will be devoted to either specific subtypes of lymphoid neoplasia (e.g. mantle cell lymphomas, follicular lymphomas, T-cell lymphomas, etc), or to the presentation of laboratory and clinical research data grouped around a biologic topic (for example, microenvironment, signalling pathway, surface antigens). The latter sessions will be introduced by an expert summarizing the topic.

“Focus on...” are parallel oral sessions highlighting abstracts of scientific value but not selected for oral presentation during the general sessions. These sessions will be run in parallel and each will be focused on a particular topic. The one-hour sessions will consist of six presentations of 10 minutes each, including discussion.

Clinical discussion sessions have presenters of outstanding centers addressing cases which are not trivial nor very rare, but rather situations commonly encountered but the solution of which remains controversial. The 2013 and 2015 format (a sort of a US vs. Europe debate, with Mayo Clinic vs Lysa in 2013 and New York centers vs FIL in 2015) was very well received and in 2017 again the following Californian vs German experts will be discussing:

1) Hodgkin lymphoma: Ranjana H. Advani, Stanford vs Peter Borchmann, Cologne
2) Indolent lymphoma: Thomas Kipps, San Diego vs Martin Dreyling, Munich
3) T-Cell: Lauren C. Pinter-Brown, Orange vs Gerald Wulf, Göttingen
4) Difficult pathological cases: Steven T. Rosen, Duarte vs Ulrich Dührsen, Essen
5) CLL: Susan M. O’Brien, Orange vs Stephan Stilgenbauer, Ulm
6) Aggressive lymphoma: Sven De Vos, Santa Monica vs Georg Lenz, Münster
7) Pediatric and adolescent lymphoma: Catherine Bollard, Washington, DC vs Birgit Burkhardt, Münster
8) Radiotherapy for lymphoma: Richard Hoppe, Stanford vs George Mikhaeel, London (UK)

Special sessions devoted to radiotherapy are organized in collaboration with ILROG (International Lymphoma Radiation Oncology Group): a first satellite workshop open to all 14-ICML attendees and a second one open to radiation oncologists only will possibly take place. Details will be available closer to the event at
A special session on “Contouring in Modern Lymphoma Radiotherapy Planning” will be held on Saturday June 17, 08:00 – 10:30, for max. 30 lymphoma radiation oncologists (pre-registration at This email address is being protected from spambots. You need JavaScript enabled to view it. is necessary).

The Ongoing trials session will comprise abstracts describing ongoing trials. Conditions for being selected for presentation at this session are:

  • already started enrolment,
  • still possible accrual of new patients.

The session should not be regarded as an advertisement for new drugs. Trials which are close to completion (i.e. not available for other possible participants) and closed trials will not be considered for presentation.

Educational symposia (parallel sessions)
- Immunotherapy in Lymphoma
Speakers: Stephen M. Ansell, Rochester, MN (USA) - chair, Federico Caligaris-Cappio, Milan (Italy) and David G. Maloney, Seattle, WA (USA)
- Aggressive Lymphoma
Speakers: Elias Campo, Barcelona (Spain) - chair, Riccardo Dalla-Favera, New York, NY (USA) and Sonali M. Smith, Chicago, IL (USA)

Key Note Lectures
- Henry Kaplan Memorial Lecture and ICML prize
Immunotherapy comes of age to treat lymphoma
Ronald Levy, Stanford, CA (USA)
- Gianni Bonadonna Memorial Lecture (sponsored by American Association for Cancer Research)
Genetic signatures and targetable pathways in lymphoid malignancies
Margaret A. Shipp, Boston, MA (USA)
- John Ultmann Memorial Lecture (sponsored by European School of Oncology)
Genomes in transit: what multi-omics can tell us on lymphomas
Rein Siebert, Kiel (Germany)

14-ICML Highlights
“Take home messages”
Speaker TBD

1.    The costs of lymphoma care: health economic issues
M.F. Fey, Bern (Switzerland)
2.    Chemotherapy-free lymphoma treatment?
J.W. Friedberg, Rochester, NY (USA)
3.    Role of stem cell transplant for lymphoma in 2017
J.G. Gribben, London (UK)
4.    Role and timing of new drugs in CLL
M. Hallek, Cologne (Germany)
5.    Response-adapted therapy in HL
P.W.M. Johnson, Southampton (UK)
6.    The updated WHO classification
L. Quintanilla-Martinez, Tuebingen (Germany)
7.    The multiple faces of Marginal Zone Lymphomas
M. Raderer, Vienna (Austria)
8.    Management of aggressive lymphoma in the very elderly patient
C. Thieblemont, Paris (France)
9.    Disease-oriented treatment of T-cell lymphoma
K. Tobinai, Tokyo (Japan)
10.    Late sequelae in lymphoma survivors
F. Van Leeuwen, Amsterdam (Netherlands)
11.    Clinical applications of genome studies
A. Younes, New York, NY (USA)
12.    ALCL and PTCL: What can pediatric and adult oncologists learn from each other?
L. Brugières, Villejuif (France) and speaker TBD

The Kaplan Lecture is a recognition of a lifetime achievement, for outstanding accomplishments in the field of lymphoma study and cure. It has previously been conferred to:
1984: R. Gallo, Bethesda, MD (USA)
1987: G. Köhler †, Freiburg (Germany)
1990: V. De Vita, New York, NY (USA)
1993: G. Bonadonna †, Milan (Italy)
1996: S.A. Rosenberg, Stanford, CA (USA) and J.O. Armitage, Omaha, NE (USA)
1999: P.G. Isaacson, London (UK)
2002: V. Diehl, Cologne (Germany)
2005: G.P. Canellos, Boston, MA (USA)
2008: B. Coiffier, Pierre Bénite (France)
2011: R. Dalla-Favera, New York, NY (USA)
2013: F. Cavalli, Bellinzona (Switzerland)
2015: L.M. Staudt, Bethesda, MD (USA)

You can download the Scientific Program at glance here.